Over the last decade, although the prescription of GLP-1 RAs has increased slightly, overall usage remains low compared with other glucose-lowering medications, such as metformin, sulfonylureas and dipeptidyl peptidase 4 inhibitors (DPP4i), regardless of CV disease status [30,31,32,33]
One of the earliest red flags involved anesthesia
In case of pre-existing heart disease, consult a healthcare professional
When patients hear that real people in a structured program saw broad systemic improvement after one year, it reframes the conversation from a weight loss drug to metabolic medicine with meaningful outcomes.
Even small adjustments in IGF-1 LR3 dosing can significantly affect physiological response
Contact your GP if taste changes prevent adequate food or fluid intake, cause unintentional weight loss beyond treatment goals, accompany severe abdominal pain, or significantly affect your quality of life